Loading...

Marina Tolou-Shams, PhD

TitleAssociate Professor
SchoolUCSF School of Medicine
DepartmentPsychiatry
Address1001 Potrero Ave
San Francisco CA 94110
Phone415-206-2212
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    Dr. Tolou-Shams is a UCSF Associate Professor, In Residence in the Department of Psychiatry and Division Director of Infant, Child and Adolescent Psychiatry at Zuckerberg SF General Hospital. Prior to joining the UCSF faculty, she held an appointment as Associate Professor (Research) in the Department of Psychiatry and Behavior at Brown Medical School. Over the past decade her roles have included serving as the Director of the Rhode Island Family Court, Mental Health Clinic, the Director of the Substance Abuse Treatment Service at the Rhode Island Training School and Assistant Director of the Forensic Psychiatry Evaluation Service of Rhode Island Hospital. Dr. Tolou-Shams received her Ph.D. in Clinical Psychology in 2004 from the University of Illinois at Chicago. She completed her postdoctoral clinical and research training through the Brown University Psychology Training Consortium. She is trained as a pediatric and forensic psychologist and has many years of clinical experience with assessing and treating high-risk adolescents and their families. Dr. Tolou-Shams is also an active clinical researcher who focuses on developing evidence-based mental health, substance abuse and HIV risk reduction interventions for court-involved, non-incarcerated (CINI) juvenile offenders. She is currently the Principal Investigator of several NIH-funded trials aimed toward improving behavioral health outcomes and reducing health disparities for juvenile justice youth, including specific emphasis on interventions for CINI girls.


    Collapse Research 
    Collapse Research Activities and Funding
    Juvenile Court Approaches to Reduce Reproductive Health Disparities
    NIH/NICHD R21HD082330Sep 1, 2015 - Aug 31, 2017
    Role: Principal Investigator
    Juvenile Court Approaches to Reduce Reproductive Health Disparities
    NIH/NICHD R21HD082330Sep 1, 2015 - Aug 31, 2017
    Role: Principal Investigator
    Juvenile Court Approaches to Reduce Reproductive Health Disparities
    NIH/NICHD R21HD082330Sep 1, 2015 - Aug 31, 2017
    Role: Principal Investigator
    Juvenile Court Approaches to Reduce Reproductive Health Disparities
    NIH/NICHD R21HD082330Sep 1, 2015 - Aug 31, 2017
    Role: Principal Investigator
    Juvenile Court Approaches to Reduce Reproductive Health Disparities
    NIH/NICHD R21HD082330Sep 1, 2015 - Aug 31, 2017
    Role: Principal Investigator
    Juvenile Court Approaches to Reduce Reproductive Health Disparities
    NIH/NICHD R21HD082330Sep 1, 2015 - Aug 31, 2017
    Role: Principal Investigator
    Gender-Responsive Drug Use Treatment for Juvenile Justice Girls
    NIH/NIDA R01DA035231Sep 1, 2014 - Aug 31, 2019
    Role: Principal Investigator
    Gender-Responsive Drug Use Treatment for Juvenile Justice Girls
    NIH/NIDA R01DA035231Sep 1, 2014 - Aug 31, 2019
    Role: Principal Investigator
    Gender-Responsive Drug Use Treatment for Juvenile Justice Girls
    NIH/NIDA R01DA035231Sep 1, 2014 - Aug 31, 2019
    Role: Principal Investigator
    Gender-Responsive Drug Use Treatment for Juvenile Justice Girls
    NIH/NIDA R01DA035231Sep 1, 2014 - Aug 31, 2019
    Role: Principal Investigator
    Gender-Responsive Drug Use Treatment for Juvenile Justice Girls
    NIH/NIDA R01DA035231Sep 1, 2014 - Aug 31, 2019
    Role: Principal Investigator
    Gender-Responsive Drug Use Treatment for Juvenile Justice Girls
    NIH/NIDA R01DA035231Sep 1, 2014 - Aug 31, 2019
    Role: Principal Investigator
    Drug Use and HIV/STI Risk Trajectories in Court-Involved, Non-Incarcerated Youth
    NIH/NIDA R01DA034538Jul 1, 2013 - Mar 31, 2018
    Role: Principal Investigator
    Drug Use and HIV/STI Risk Trajectories in Court-Involved, Non-Incarcerated Youth
    NIH/NIDA R01DA034538Jul 1, 2013 - Mar 31, 2018
    Role: Principal Investigator
    Drug Use and HIV/STI Risk Trajectories in Court-Involved, Non-Incarcerated Youth
    NIH/NIDA R01DA034538Jul 1, 2013 - Mar 31, 2018
    Role: Principal Investigator
    Drug Use and HIV/STI Risk Trajectories in Court-Involved, Non-Incarcerated Youth
    NIH/NIDA R01DA034538Jul 1, 2013 - Mar 31, 2018
    Role: Principal Investigator
    Drug Use and HIV/STI Risk Trajectories in Court-Involved, Non-Incarcerated Youth
    NIH/NIDA R01DA034538Jul 1, 2013 - Mar 31, 2018
    Role: Principal Investigator
    Drug Use and HIV/STI Risk Trajectories in Court-Involved, Non-Incarcerated Youth
    NIH/NIDA R01DA034538Jul 1, 2013 - Mar 31, 2018
    Role: Principal Investigator
    HIV Prevention in the Family Drug Court
    NIH/NIDA K23DA021532Feb 1, 2008 - Jan 31, 2014
    Role: Principal Investigator
    HIV Prevention in the Family Drug Court
    NIH/NIDA K23DA021532Feb 1, 2008 - Jan 31, 2014
    Role: Principal Investigator
    HIV Prevention in the Family Drug Court
    NIH/NIDA K23DA021532Feb 1, 2008 - Jan 31, 2014
    Role: Principal Investigator
    HIV Prevention in the Family Drug Court
    NIH/NIDA K23DA021532Feb 1, 2008 - Jan 31, 2014
    Role: Principal Investigator
    HIV Prevention in the Family Drug Court
    NIH/NIDA K23DA021532Feb 1, 2008 - Jan 31, 2014
    Role: Principal Investigator
    HIV Prevention in the Family Drug Court
    NIH/NIDA K23DA021532Feb 1, 2008 - Jan 31, 2014
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Global Health
    Collapse Featured Publications

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Tolou-Shams M, Conrad S, Louis A, Shuford SH, Brown LK. HIV testing among non-incarcerated substance-abusing juvenile offenders. Int J Adolesc Med Health. 2015 Nov 1; 27(4):467-9. PMID: 25720046.
      View in: PubMed
    2. Bottoms BL, Goodman GS, Tolou-Shams M, Diviak KR, Shaver PR. Religion-Related Child Maltreatment: A Profile of Cases Encountered by Legal and Social Service Agencies. Behav Sci Law. 2015 Aug; 33(4):561-79. PMID: 26294386.
      View in: PubMed
    3. Janopaul-Naylor E, Brown JD, Lowenhaupt EA, Tolou-Shams M. Assessment and treatment of substance abuse in the juvenile justice population. Adolesc Med State Art Rev. 2014 Apr; 25(1):215-29. PMID: 25022195.
      View in: PubMed
    4. Tolou-Shams M, Rizzo CJ, Conrad SM, Johnson S, Oliveira C, Brown LK. Predictors of detention among juveniles referred for a court clinic forensic evaluation. J Am Acad Psychiatry Law. 2014; 42(1):56-65. PMID: 24618520.
      View in: PubMed
    5. Conrad SM, Tolou-Shams M, Rizzo CJ, Placella N, Brown LK. Gender differences in recidivism rates for juvenile justice youth: the impact of sexual abuse. Law Hum Behav. 2014 Aug; 38(4):305-14. PMID: 24127890; PMCID: PMC4351738.
    6. de Dios MA, Kuo C, Hernandez L, Clark US, Wenze SJ, Boisseau CL, Hunter HL, Reddy MK, Tolou-Shams M, Zlotnick C. The development of a diversity mentoring program for faculty and trainees: A program at the Brown Clinical Psychology Training Consortium. Behav Ther (N Y N Y). 2013 Jun; 36(5):121-126. PMID: 25346563.
      View in: PubMed
    7. Houck CD, Hadley W, Tolou-Shams M, Brown L. Truancy is associated with sexual risk among early adolescents. J Dev Behav Pediatr. 2012 Nov-Dec; 33(9):728-31. PMID: 23117598; PMCID: PMC3488264.
    8. Brown LK, Houck C, Lescano C, Donenberg G, Tolou-Shams M, Mello J. Affect regulation and HIV risk among youth in therapeutic schools. AIDS Behav. 2012 Nov; 16(8):2272-8. PMID: 22669595; PMCID: PMC3496428.
    9. Tolou-Shams M, Tarantino N, McKirnan DJ, Dyslin KJ. Depressive Symptoms, Illicit Drug Use and HIV/STI Risk Among Sexual Minority Young Adults. J Gay Lesbian Ment Health. 2013 Jan 11; 17(1):96-102. PMID: 23504693.
      View in: PubMed
    10. Tolou-Shams M, Houck CD, Nugent N, Conrad SM, Reyes A, Brown LK. Alcohol Use and HIV Risk among Juvenile Drug Court Offenders. J Soc Work Pract Addict. 2012; 12(2):178-188. PMID: 22997487.
      View in: PubMed
    11. Tolou-Shams M, Hadley W, Conrad SM, Brown LK. The Role of Family Affect in Juvenile Drug Court Offenders' Substance Use and HIV Risk. J Child Fam Stud. 2012 Jun 1; 21(3):449-456. PMID: 22661883.
      View in: PubMed
    12. Tolou-Shams M, Houck C, Conrad SM, Tarantino N, Stein LA, Brown LK. HIV prevention for juvenile drug court offenders: a randomized controlled trial focusing on affect management. J Correct Health Care. 2011 Jul; 17(3):226-32. PMID: 21474529; PMCID: PMC3445619.
    13. Hadley W, Hunter HL, Tolou-Shams M, Lescano C, Thompson A, Donenberg G, DiClemente R, Brown LK. Monitoring challenges: a closer look at parental monitoring, maternal psychopathology, and adolescent sexual risk. J Fam Psychol. 2011 Apr; 25(2):319-23. PMID: 21417519; PMCID: PMC3466599.
    14. McKirnan DJ, Tolou-Shams M, Courtenay-Quirk C. The Treatment Advocacy Program: a randomized controlled trial of a peer-led safer sex intervention for HIV-infected men who have sex with men. J Consult Clin Psychol. 2010 Dec; 78(6):952-63. PMID: 20919760.
      View in: PubMed
    15. Tolou-Shams M, Ewing SW, Tarantino N, Brown LK. Crack and Cocaine Use among Adolescents in Psychiatric Treatment: Associations with HIV Risk. J Child Adolesc Subst Abuse. 2010 Jan 1; 19(2):122-134. PMID: 22224066.
      View in: PubMed
    16. Tolou-Shams M, Stewart A, Fasciano J, Brown LK. A review of HIV prevention interventions for juvenile offenders. J Pediatr Psychol. 2010 Apr; 35(3):250-61. PMID: 19741021; PMCID: PMC2902828.
    17. Brown LK, Tolou-Shams M, Brave Whiteley L. Youths' HIV risk in the justice system: a critical but neglected issue. J Am Acad Child Adolesc Psychiatry. 2008 Aug; 47(8):845-6. PMID: 18645416.
      View in: PubMed
    18. Grossman C, Hadley W, Brown LK, Houck CD, Peters A, Tolou-Shams M. Adolescent sexual risk: factors predicting condom use across the stages of change. AIDS Behav. 2008 Nov; 12(6):913-22. PMID: 18427971.
      View in: PubMed
    19. Tolou-Shams M, Brown LK, Houck C, Lescano CM. The association between depressive symptoms, substance use, and HIV risk among youth with an arrest history. J Stud Alcohol Drugs. 2008 Jan; 69(1):58-64. PMID: 18080065.
      View in: PubMed
    20. Tolou-Shams M, Payne N, Houck C, Pugatch D, Beausoleil N, Brown LK. HIV testing among at-risk adolescents and young adults: a prospective analysis of a community sample. J Adolesc Health. 2007 Dec; 41(6):586-93. PMID: 18023788.
      View in: PubMed
    21. McKirnan D, Houston E, Tolou-Shams M. Is the Web the culprit? Cognitive escape and Internet sexual risk among gay and bisexual men. AIDS Behav. 2007 Jan; 11(1):151-60. PMID: 16779660.
      View in: PubMed
    22. Tolou-Shams M, Brown LK, Gordon G, Fernandez I. Arrest history as an indicator of adolescent/young adult substance use and HIV risk. Drug Alcohol Depend. 2007 Apr 17; 88(1):87-90. PMID: 17092660.
      View in: PubMed
    23. Brown LK, Tolou-Shams M, Lescano C, Houck C, Zeidman J, Pugatch D, Lourie KJ. Depressive symptoms as a predictor of sexual risk among African American adolescents and young adults. J Adolesc Health. 2006 Sep; 39(3):444.e1-8. PMID: 16919811.
      View in: PubMed
    24. McKirnan DJ, Tolou-Shams M, Turner L, Dyslin K, Hope B. Elevated risk for tobacco use among men who have sex with men is mediated by demographic and psychosocial variables. Subst Use Misuse. 2006; 41(8):1197-208. PMID: 16798685.
      View in: PubMed
    25. Houck CD, Lescano CM, Brown LK, Tolou-Shams M, Thompson J, Diclemente R, Fernandez MI, Pugatch D, Schlenger WE, Silver BJ. "Islands of Risk": subgroups of adolescents at risk for HIV. J Pediatr Psychol. 2006 Jul; 31(6):619-29. PMID: 16120764.
      View in: PubMed
    26. Di Sclafani V, Tolou-Shams M, Price LJ, Fein G. Neuropsychological performance of individuals dependent on crack-cocaine, or crack-cocaine and alcohol, at 6 weeks and 6 months of abstinence. Drug Alcohol Depend. 2002 Apr 1; 66(2):161-71. PMID: 11906803; PMCID: PMC2857526.
    27. Fein G, Di Sclafani V, Cardenas VA, Goldmann H, Tolou-Shams M, Meyerhoff DJ. Cortical gray matter loss in treatment-naïve alcohol dependent individuals. Alcohol Clin Exp Res. 2002 Apr; 26(4):558-64. PMID: 11981133; PMCID: PMC2435064.
    28. Di Sclafani V, Clark HW, Tolou-Shams M, Bloomer CW, Salas GA, Norman D, Fein G. Premorbid brain size is a determinant of functional reserve in abstinent crack-cocaine and crack-cocaine-alcohol-dependent adults. J Int Neuropsychol Soc. 1998 Nov; 4(6):559-65. PMID: 10050360.
      View in: PubMed
    29. DI Sclafani V, Truran DL, Bloomer C, Tolou-Shams M, Clark HW, Norman D, Hannauer D, Fein G. Abstinent chronic crack-cocaine and crackcocaine/alcohol abusers evidence normal hippocampal volumes on MRI despite persistent cognitive impairments. Addict Biol. 1998 Jul; 3(3):261-70. PMID: 26734920.
      View in: PubMed
    Marina's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _
    Back to TOP